Table 3.
Multinomial logistic regression analysis: impact of higher GA (≥16.0%) on each quartile of infarct volume (reference = Q-25).
| GA ≥ 16.0% (n = 217) | HbA1c ≥ 6.5% (n = 203) | GA/HbA1c ratio | ||||
|---|---|---|---|---|---|---|
| Adjusted ORa | 95% CI | Adjusted ORb | 95% CI | Adjusted ORa | 95% CI | |
| Q-25 | Reference | |||||
| Q-50 | 1.58 | 0.65–3.88 | 2.59 | 1.04–6.48 | 0.91 | 0.41–2.01 |
| Q-75 | 1.48 | 0.56–3.97 | 2.77 | 1.01–7.62 | 0.66 | 0.27–1.64 |
| Q-100 | 3.76 | 1.05–13.45 | 3.39 | 1.08–10.69 | 2.95 | 1.29–6.75 |
GA, glycated albumin; HbA1c, glycated hemoglobin; OR, odds ratio; CI, confidence interval.
Adjusted for age, sex, hypertension, stroke mechanism, stroke severity, medications for hypertension, medications for DM, prior antithrombotic agents use, statin use, initial random glucose, serum albumin, and glycated hemoglobin.
Adjusted for age, sex, prior stroke, stroke mechanism, stroke severity, interval from onset to visit, current smoking, prior antithrombotic agents use, atrial fibrillation, reperfusion therapy, medications for DM, previous antithrombotic agents, statin use, creatinine, low-density lipoprotein, glycated hemoglobin and initial random glucose.